/* Key Metrics */
Total Revenue (FY2025)
$94.2B
↑ 6.2% YoY
Net Income (FY2025)
$14.8B
↑ 13.0% YoY
EPS (Diluted)
$8.42
↑ 7.1% YoY
EBITDA Margin
28.4%
↑ 1.2% YoY
Cash & Equivalents
$21.3B
↓ 4.5% YoY
Debt-to-Equity
0.68
↓ Improved
/* Financial Tables */
Fiscal Year Revenue COGS Gross Profit OpEx Net Income EPS
FY 2025
Full Year $94.21B $61.45B $32.76B $18.92B $14.82B $8.42
FY 2024
Full Year $88.68B $58.12B $30.56B $17.84B $13.11B $7.85
FY 2023
Full Year $82.39B $54.88B $27.51B $16.22B $11.89B $7.12
Quarter Revenue Gross Profit Net Income EPS
Fiscal Year 2025
Q1 2025$21.84B$7.41B$3.28B$1.89
Q2 2025$23.12B$7.88B$3.72B$2.14
Q3 2025$23.95B$8.15B$3.81B$2.19
Q4 2025$25.30B$9.32B$4.01B$2.30
/* Chart */
📈 5-Year Revenue Trend
/* Grid */ /* Y-Axis Labels */ $100B $80B $60B $40B /* Bars */ /* X-Axis Labels */ 2021 2022 2023 2024 2025
$94.2B
/* Downloads */

Regulatory Filings & Reports

/* Disclosures */
Forward-Looking Statements Disclaimer: This page contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors that may cause Aevum Zenth Conglomerate's actual results to differ materially from those projected. All financial data presented herein is unaudited except for FY2025 figures, which have been reviewed by independent auditors. Historical performance is not indicative of future results. Please consult SEC filings for complete risk factors and accounting policies.